Esketamine on Postoperative Sleep Disturbance of Patients Undergoing Spinal Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorBeijing Tiantan Hospital

About this trial

The goal of this clinical trial is to learn about the effect of intraoperative esketamine infusion on postoperative sleep disturbance(PSD) of patients undergoing spinal surgery. The main aims to answer are:

* To explore the effect of intraoperative infusion of esketamine on the incidence of postoperative sleep disturbance and sleep quality in patients undergoing spinal surgery. * To explore the effect of intraoperative infusion of esketamine on postoperative pain, anxiety and depression ; Participants will be patients undergoing spinal surgery with general anesthesia at Beijing Tiantan Hospital. 0.3mg/kg/h esketamine or saline will be infused during surgery . The incidence of sleep disturbance , sleep quality, pain scores, hospital anxiety and depression scores and perioperative adverse events after surgery will be investigated.

Eligibility criteria

Qualifiers

18-65 years old,

American Society of Anesthesiologist (ASA) Physical Status classification I to III ;

Patients scheduled to undergo elective spinal surgery under general anesthesia;

Signed informed consent ;

Disqualifiers

BMI > 35kg / m2 ;

Severe lesions of important organs and systems ;

The estimated duration of surgery is more than 4 hours

Patients who were retained tracheal intubation or admitted to intensive care unit (ICU) postoperatively.

Trial design

Treatments tested in this trial

  • Esketamine
  • saline

Treatment groups

156 Participants
are divided into 2 treatment groups

Sponsors and collaborators